US Supreme Court Skips Case Seeking to Limit Patent Royalties

The US Supreme Court declined to hear a case that asked whether patent holders can collect royalties after their patents expire, rejecting Atrium Medical Corp.'s request in a licensing fight with CR Bard Inc.

The justices on Monday rejected Atrium’s petition for a writ of certiorari, allowing the US Court of Appeals for the Ninth Circuit’s August 2024 ruling to stand. That decision upheld Bard’s right to enforce a $15 million-a-year minimum payment clause in a license agreement after its US patent on vascular stents expired. The court noted that Justice Samuel Alito didn’t participate in the decision to deny ...